Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia

Charles H. Adler, Stewart A. Factor, Mitchell Brin, Kapil Dev Sethi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period.

Original languageEnglish (US)
Pages (from-to)158-161
Number of pages4
JournalMovement Disorders
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2002

Fingerprint

Type A Botulinum Toxins
Dystonia
Dystonic Disorders
Intramuscular Injections
Injections
Therapeutics

Keywords

  • Botulinum toxin
  • Immunoresistance
  • Oromandibular dystonia

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia. / Adler, Charles H.; Factor, Stewart A.; Brin, Mitchell; Sethi, Kapil Dev.

In: Movement Disorders, Vol. 17, No. 1, 01.01.2002, p. 158-161.

Research output: Contribution to journalArticle

Adler, Charles H. ; Factor, Stewart A. ; Brin, Mitchell ; Sethi, Kapil Dev. / Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia. In: Movement Disorders. 2002 ; Vol. 17, No. 1. pp. 158-161.
@article{2005d86647f3473ab412f92571c70b20,
title = "Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia",
abstract = "Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period.",
keywords = "Botulinum toxin, Immunoresistance, Oromandibular dystonia",
author = "Adler, {Charles H.} and Factor, {Stewart A.} and Mitchell Brin and Sethi, {Kapil Dev}",
year = "2002",
month = "1",
day = "1",
doi = "10.1002/mds.10001",
language = "English (US)",
volume = "17",
pages = "158--161",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia

AU - Adler, Charles H.

AU - Factor, Stewart A.

AU - Brin, Mitchell

AU - Sethi, Kapil Dev

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period.

AB - Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period.

KW - Botulinum toxin

KW - Immunoresistance

KW - Oromandibular dystonia

UR - http://www.scopus.com/inward/record.url?scp=0036461016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036461016&partnerID=8YFLogxK

U2 - 10.1002/mds.10001

DO - 10.1002/mds.10001

M3 - Article

C2 - 11835455

AN - SCOPUS:0036461016

VL - 17

SP - 158

EP - 161

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 1

ER -